Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about METABOLIC SYNDROME: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
graph TD
METABOLIC_SYNDROME["METABOLIC SYNDROME"]
METABOLIC_SYNDROME -->|"activates"| Lipid_Metabolism["Lipid Metabolism"]
METABOLIC_SYNDROME -->|"activates"| Mtor["Mtor"]
METABOLIC_SYNDROME -->|"activates"| Lysosomal_Degradation["Lysosomal Degradation"]
METABOLIC_SYNDROME -->|"activates"| Autophagy["Autophagy"]
METABOLIC_SYNDROME -->|"target for"| Epigenetic["Epigenetic"]
METABOLIC_SYNDROME -->|"target for"| Tgf__["Tgf-Beta"]
METABOLIC_SYNDROME -->|"target for"| Insulin_Signaling["Insulin Signaling"]
METABOLIC_SYNDROME -->|"target for"| Ferroptosis["Ferroptosis"]
METABOLIC_SYNDROME -->|"regulates"| Immune_Response["Immune Response"]
ACTB["ACTB"] -->|"activates"| METABOLIC_SYNDROME
PPARA["PPARA"] -->|"activates"| METABOLIC_SYNDROME
CAT["CAT"] -->|"activates"| METABOLIC_SYNDROME
SQSTM1["SQSTM1"] -->|"activates"| METABOLIC_SYNDROME
RPS6KB1["RPS6KB1"] -->|"activates"| METABOLIC_SYNDROME
RAB7A["RAB7A"] -->|"activates"| METABOLIC_SYNDROME
SREBF1["SREBF1"] -->|"activates"| METABOLIC_SYNDROME
EIF4EBP1["EIF4EBP1"] -->|"activates"| METABOLIC_SYNDROME
CTSD["CTSD"] -->|"activates"| METABOLIC_SYNDROME
PPARGC1A["PPARGC1A"] -->|"activates"| METABOLIC_SYNDROME| Target | Relation | Type | Str |
|---|---|---|---|
| Insulin Resistance | associated_with | disease | 1.00 |
| Obesity | associated_with | disease | 1.00 |
| Lipid Metabolism | activates | pathway | 1.00 |
| Als | associated_with | disease | 0.95 |
| Type 2 Diabetes | associated_with | disease | 0.95 |
| Non-Alcoholic Fatty Liver Disease | risk_factor_for | disease | 0.90 |
| RAS | causes | pathway | 0.90 |
| Lipid Metabolism | regulates | pathway | 0.90 |
| Als | regulates | disease | 0.85 |
| Obesity | regulates | disease | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Insulin Resistance | activates | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Oxidative Stress | activates | pathway | 0.80 |
| Pi3K/Akt | activates | pathway | 0.80 |
| Glycolysis | activates | pathway | 0.80 |
| Fatty Liver | activates | disease | 0.75 |
| Atherosclerosis | regulates | disease | 0.75 |
| Inflammation | regulates | disease | 0.75 |
| Oxidative Stress | regulates | pathway | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Hepatitis | associated_with | disease | 0.75 |
| Fatty Liver | regulates | disease | 0.75 |
| Cholesterol | activates | pathway | 0.70 |
| Tgf-Β | therapeutic_target | pathway | 0.70 |
| Mtor | therapeutic_target | pathway | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| Microrna | regulates | pathway | 0.70 |
| Oxidative Stress | therapeutic_target | pathway | 0.70 |
| Immune Response | regulates | pathway | 0.70 |
| Oxidative Stress | treats | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Cholesterol | associated_with | pathway | 0.70 |
| Oxidative Stress | associated_with | pathway | 0.70 |
| Cholesterol | regulates | pathway | 0.70 |
| Insulin Resistance | causes | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Type 2 Diabetes | regulates | disease | 0.65 |
| Type 2 Diabetes | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Insulin Signaling | activates | pathway | 0.65 |
| Atherosclerosis | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Autophagy | associated_with | pathway | 0.65 |
| Nafld | contributes_to | disease | 0.65 |
| Insulin Resistance | regulates | disease | 0.65 |
| Ferroptosis | activates | pathway | 0.60 |
| Autophagy | treats | pathway | 0.60 |
| Metastasis | therapeutic_target | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INSULIN RESISTANCE | activates | gene | 1.00 |
| Hypertension | associated_with | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| INSULIN RESISTANCE | associated_with | gene | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| AMPK | therapeutic_target | gene | 1.00 |
| Cancer | therapeutic_target | disease | 0.95 |
| INFLAMMATION | activates | gene | 0.95 |
| AKT | activates | gene | 0.95 |
| PI3K | activates | gene | 0.95 |
| INFLAMMATION | regulates | gene | 0.95 |
| Insulin Resistance | associated_with | phenotype | 0.90 |
| CIRCADIAN DISRUPTION | associated_with | entity | 0.90 |
| Mitochondrial Dysfunction | associated_with | process | 0.90 |
| Insomnia | risk_factor_for | disease | 0.90 |
| Circadian Clock Pathway | therapeutic_target | pathway | 0.85 |
| SQSTM1 | activates | gene | 0.85 |
| Diabetes | activates | disease | 0.85 |
| RUBCN deficiency | causes | phenotype | 0.85 |
| OXIDATIVE STRESS | activates | gene | 0.85 |
| INFLAMMATION | associated_with | gene | 0.85 |
| OXIDATIVE STRESS | associated_with | gene | 0.85 |
| Obesity | activates | disease | 0.85 |
| MITOCHONDRIA | associated_with | gene | 0.85 |
| Tumor | activates | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| INFLAMMATION | therapeutic_target | gene | 0.85 |
| GENES | regulates | gene | 0.85 |
| circadian clock | regulates | pathway | 0.85 |
| GENES | activates | gene | 0.85 |
| circadian rhythm disruption | risk_factor_for | process | 0.85 |
| Rubcn Deficiency | associated_with | phenotype | 0.85 |
| Tumor | therapeutic_target | disease | 0.85 |
| IL-6 | activates | gene | 0.85 |
| Circadian Disruption | risk_factor_for | process | 0.85 |
| IL-6 | causes | gene | 0.85 |
| MITOCHONDRIA | regulates | gene | 0.85 |
| Diabetes | regulates | disease | 0.85 |
| ATP | activates | gene | 0.85 |
| OXIDATIVE STRESS | regulates | gene | 0.85 |
| DIABETES MELLITUS | activates | gene | 0.85 |
| DIABETES MELLITUS | associated_with | gene | 0.85 |
| Cardiovascular | regulates | disease | 0.85 |
| Clock Gene Expression | contributes_to | process | 0.80 |
| AMPK | therapeutic_target | pathway | 0.80 |
| mitochondrial dysfunction | implicated_in | process | 0.80 |
| Circadian Disruption | contributes_to | process | 0.80 |
| lipid metabolism | involved_in | pathway | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning METABOLIC SYNDROME in their description or question text
No additional research found